|
|
Issuer: Immunic, Inc.
/ Key words: Conference
Immunic to Participate in Investor and Scientific Conferences in March
07.03.2024 / 12:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
Immunic to Participate in Investor and Scientific Conferences in March... Lire le communiqué |
|
| |
|
| |
|
|
Issuer: Immunic, Inc.
/ Key words: Conference
Immunic Presents Data From Phase 2 CALLIPER and CALVID1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
29.02.2024 / 12:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
Immunic Presents Data From Phase 2 CALLI... Lire le communiqué |
|
| |
|
| |
|
|
Issuer: Immunic, Inc.
/ Key words: Annual Results
Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update
22.02.2024 / 12:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
Immunic, Inc. Reports Year End 2023 Financial Results and Provides... Lire le communiqué |
|
| |
|
| |
|
|
Issuer: Immunic, Inc.
/ Key words: Miscellaneous
Immunic, Inc. to Announce Financial Results for the Year Ended December 31, 2023, and Provide Corporate Update
15.02.2024 / 12:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
Immunic, Inc. to Announce Financial Resul... Lire le communiqué |
|
| |
|
| |
|
|
Issuer: Immunic, Inc.
/ Key words: Conference
Immunic to Participate in Investor and Scientific Conferences in February
01.02.2024 / 12:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
Immunic to Participate in Investor and Scientific Conferences in February... Lire le communiqué |
|
| |
|
| |
|
|
Issuer: Immunic, Inc.
/ Key words: Miscellaneous/Financing
Immunic Highlights 2023 Accomplishments and Upcoming Milestones
05.01.2024 / 12:35 CET/CEST
The issuer is solely responsible for the content of this announcement.
Immunic Highlights 2023 Accomplishments and Upcoming Milestones ... Lire le communiqué |
|
| |
|
| |
|
|
Issuer: Immunic, Inc.
/ Key words: Financing
Immunic, Inc. Announces Private Placement of up to $240 Million
05.01.2024 / 12:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
Immunic, Inc. Announces Private Placement of up to $240 Million
NEW YORK, J... Lire le communiqué |
|
| |
|
| |
